** Shares of Argent BioPharma RGT.AX rise 24.1% to A$0.180
** Drug discovery firm says it has entered a strategic manufacturing partnership with ECCPharm
** Under the deal, ECCPharm will manufacture and batch release co’s cannabinoid therapies
** Trade vols at 3x the 30-day avg of 33,207 shares
** RGT up 5.9% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。